Investigation of Patient Benefits With a New Supporting Ostomy Product in Patients With a Newly Stoma Formation

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 25, 2021

Primary Completion Date

August 22, 2022

Study Completion Date

August 22, 2022

Conditions
Stoma IleostomyStoma Colostomy
Interventions
DEVICE

Heylo

Test of the supporting product (test product) for a 12 weeks period. No additional intervention will be conducted. A few follow up nurse calls to assess few endpoints together with subject. All remaining endpoints are captured via surveys send to the subjects every 14 days.

Trial Locations (10)

Unknown

Southmead/North Bristol NHS Trust, Bristol

Chelsea & Westminster Hospital, Chelsea

Devon/Royal Devon and Exeter NHS Foundation Trust, Exeter

Norfolk/James Paget University Hospitals NHS Foundation Trust, Great Yarmouth

Leeds/Leeds Teaching Hospitals NHS Trust, Leeds

Illingworth, Manchester

Middlesbrough/South Tees NHS trust, James Cook University Hospital, Middlesbrough

Petersborough/ North West Anglia NHS Foundation trust, Petersborough City Hospital, Peterborough

Preston/Lancashire Teaching Hospitals NHS Trust, Royal Preston Hospital, Preston

NE3 3HD

Newcastle University/The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Coloplast A/S

INDUSTRY

NCT05135754 - Investigation of Patient Benefits With a New Supporting Ostomy Product in Patients With a Newly Stoma Formation | Biotech Hunter | Biotech Hunter